These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
954 related articles for article (PubMed ID: 28690012)
1. Prognostic Value of Metabolic Parameters of Metastatic Lymph Nodes on Jin F; Qu B; Fu Z; Zhang Y; Han A; Kong L; Yu J Clin Lung Cancer; 2018 Jan; 19(1):e101-e108. PubMed ID: 28690012 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of metabolic parameters measured by Chang H; Lee SJ; Lim J; Lee JS; Kim YJ; Lee WW J Cancer Res Clin Oncol; 2019 May; 145(5):1361-1367. PubMed ID: 30900157 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Preradiotherapy (18)F-FDG PET/CT Volumetrics in Limited-Stage Small-Cell Lung Cancer. Ong LT; Dunphy M; Foster A; Woo KM; Zhang Z; Perez CA; Pietanza CM; Rosenzweig KE; Gelblum DY; Rimner A; Wu AJ Clin Lung Cancer; 2016 May; 17(3):184-8. PubMed ID: 26320828 [TBL] [Abstract][Full Text] [Related]
5. [Prognostic value of (18)F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) in extensive-stage small cell lung cancer]. Ding CY; Guo Z; Li YY; Li TR Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):828-834. PubMed ID: 29151289 [No Abstract] [Full Text] [Related]
6. Lymph node standardized uptake values at pre-treatment Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer. Liao S; Penney BC; Wroblewski K; Zhang H; Simon CA; Kampalath R; Shih MC; Shimada N; Chen S; Salgia R; Appelbaum DE; Suzuki K; Chen CT; Pu Y Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):27-38. PubMed ID: 21946983 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of metabolic parameters measured by (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with small cell lung cancer. Zhu D; Ma T; Niu Z; Zheng J; Han A; Zhao S; Yu J Lung Cancer; 2011 Sep; 73(3):332-7. PubMed ID: 21292341 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer. Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC). Mirili C; Guney IB; Paydas S; Seydaoglu G; Kapukaya TK; Ogul A; Gokcay S; Buyuksimsek M; Yetisir AE; Karaalioglu B; Tohumcuoglu M Int J Clin Oncol; 2019 Feb; 24(2):168-178. PubMed ID: 30109543 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer. Chen HH; Chiu NT; Su WC; Guo HR; Lee BF Radiology; 2012 Aug; 264(2):559-66. PubMed ID: 22692034 [TBL] [Abstract][Full Text] [Related]
12. Comparison of prognostic values of primary tumor and nodal Lim CH; Hyun SH; Moon SH; Cho YS; Choi JY; Lee KH Eur Radiol; 2019 Oct; 29(10):5288-5297. PubMed ID: 30899978 [TBL] [Abstract][Full Text] [Related]
13. [Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma]. Wu LL; Liang JH; Wang L; Xu W; Ding CY Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):831-836. PubMed ID: 31770850 [No Abstract] [Full Text] [Related]
14. Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer. Liao S; Penney BC; Zhang H; Suzuki K; Pu Y Acad Radiol; 2012 Jan; 19(1):69-77. PubMed ID: 22142679 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer. Im HJ; Oo S; Jung W; Jang JY; Kim SW; Cheon GJ; Kang KW; Chung JK; Kim EE; Lee DS Medicine (Baltimore); 2016 May; 95(19):e3686. PubMed ID: 27175707 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents. Hwang SH; Cho A; Yun M; Choi YD; Rha SY; Kang WJ Clin Nucl Med; 2017 May; 42(5):e235-e241. PubMed ID: 28288043 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of volumetric metabolic parameters measured by [18F]fluorodeoxyglucose-positron emission tomography/computed tomography in patients with small cell lung cancer. Park SB; Choi JY; Moon SH; Yoo J; Kim H; Ahn YC; Ahn MJ; Park K; Kim BT Cancer Imaging; 2014 Apr; 14(1):2. PubMed ID: 25609313 [TBL] [Abstract][Full Text] [Related]
18. Application of novel quantitative techniques for fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer. Wang D; Koh ES; Descallar J; Pramana A; Vinod SK; Ho Shon I Asia Pac J Clin Oncol; 2016 Dec; 12(4):349-358. PubMed ID: 27550522 [TBL] [Abstract][Full Text] [Related]
19. The prognostic role of PET/CT in small-cell lung cancer. Budak E; Yanarateş A; Akgün A Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):9-13. PubMed ID: 31865009 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of Lee JW; Choi JS; Lyu J; Lee SM Lung Cancer; 2018 Apr; 118():41-47. PubMed ID: 29572001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]